Evaluation of collagen ceramic composite graft materials in a spinal fusion model.
Autogenous bone graft is highly effective in inducing a bone healing response in most clinical settings. However, significant morbidity can occur related to the harvest of an autograft. This makes the development of synthetic or purified nontissue bone grafting materials highly desirable. Both purified bovine Type I collagen and calcium phosphate ceramics have been proposed as promising osteoconductive bone graft substitute materials. One collagen ceramic composite, Collagraft, is approved for use in acute long bone fractures. This study evaluated composites of purified bovine Type I fibrillar collagen and a granular biphasic hydroxyapatite/tricalcium phosphate ceramic in the posterior segmental canine spinal fusion model. Materials were compared based on union score and mechanical testing in 3 separate fusion sites (L1-2, L3-4, L5-6). All composites were found to be inferior in union score to an equal volume of autogenous cancellous bone. In addition, the combination of the collagen ceramic composite with autogenous cancellous bone graft reduced the effectiveness of the autogenous bone graft significantly. These data should be a caution to the clinician who may consider use of collagen ceramic composites similar to Collagraft for spinal fusion applications.
Muschler
G F
GF
Department of Orthopaedic Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Negami
S
S
Hyodo
A
A
Gaisser
D
D
Easley
K
K
Kambic
H
H
D000818:Animals; D018786:Bone Substitutes / Q000627:therapeutic use*; D002130:Calcium Phosphates / Q000627:therapeutic use; D003094:Collagen / Q000627:therapeutic use; D004195:Disease Models, Animal; D004285:Dogs; D005069:Evaluation Studies as Topic; D008297:Male; D008422:Materials Testing; D019736:Prostheses and Implants; D013123:Spinal Fusion
D018786:Bone Substitutes; D002130:Calcium Phosphates; C065819:Collagraft; D003094:Collagen